(Q33273605)

25 July 2017

2 references

25 January 2021

23 October 2022

Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses? (English)

1 reference

influenza A virus subtype H3N2

25 July 2017

1 reference

13 December 2019

1 reference

28 September 2019

1 reference

3 November 2019

1 reference

31 August 2020

1 reference

18 October 2020

1 reference

25 January 2021

influenza A virus subtype H5N1

1 reference

1 reference

Kanta Subbarao

2

0 references

author name string

Laura Gillim-Ross

series ordinal

1

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 February 2007

14 references

25 July 2017

13 March 2019

23 March 2019

20 June 2019

28 September 2019

3 November 2019

27 November 2019

13 December 2019

28 April 2020

1 July 2020

31 August 2020

18 October 2020

25 January 2021

23 October 2022

14 references

25 July 2017

13 March 2019

23 March 2019

20 June 2019

28 September 2019

3 November 2019

27 November 2019

13 December 2019

28 April 2020

1 July 2020

31 August 2020

18 October 2020

25 January 2021

23 October 2022

4

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

e91

1 reference

Creative Commons CC0 License

25 July 2017

copyright license

13 references

13 March 2019

23 March 2019

20 June 2019

28 September 2019

3 November 2019

27 November 2019

13 December 2019

28 April 2020

1 July 2020

31 August 2020

18 October 2020

25 January 2021

on focus list of Wikimedia project

23 October 2022

copyright status

public domain

0 references

ScienceSource

0 references

cites work

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Strategies for mitigating an influenza pandemic

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Immunity to influenza in man

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Antiviral Activity of Antiserum Specific for an Influenza Virus Neuraminidase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Determinants of immunity to influenza infection in man

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1796911

10.1371/JOURNAL.PMED.0040091

31 October 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference

25 July 2017

1 reference